Quarterly report · Q1

Period2024-01-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥11.2bn2024-01-01 → 2024-03-31Cons.Net sales
Revenue¥46.5bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥10.8bn2023-01-01 → 2023-03-31Cons.Net sales
Operating income¥302m2024-01-01 → 2024-03-31Cons.Operating income
Operating income−¥176m2023-01-01 → 2023-03-31Cons.Operating income
Ordinary income¥266m2024-01-01 → 2024-03-31Cons.Ordinary income
Ordinary income−¥1.4bn2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥111m2023-01-01 → 2023-03-31Cons.Ordinary income
Profit before tax−¥216m2024-01-01 → 2024-03-31Cons.Income before income taxes
Profit before tax−¥81m2023-01-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥191m2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.7bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥167m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥191m2024-01-01 → 2024-03-31Cons.Profit loss
Net income−¥168m2023-01-01 → 2023-03-31Cons.Profit loss
Total assets¥71.2bnat 2024-03-31Cons.Assets
Total assets¥59.6bnat 2023-12-31Cons.Assets
Total assets¥63.3bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥40.3bnat 2024-03-31Cons.Liabilities
Total liabilities¥39.4bnat 2023-12-31Cons.Liabilities
Net assets / equity¥30.9bnat 2024-03-31Cons.Net assets
Net assets / equity¥20.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥22.5bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥18.9bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥15.8bnat 2023-12-31Cons.Cash and deposits
EPS (basic)¥1.492024-01-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-22.762023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.462023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio43.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio35.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31−¥392m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥118m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥118m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥126m
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥10.3bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥10.3bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentsegment profit2024-01-01 → 2024-03-31¥922m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥732m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥732m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥101m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-03-31¥11.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-03-31¥11.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-03-31¥694m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥425m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥52m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥52m
jpcrp040300-q1r_E27054-000Biofuel Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥227m
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥10.0bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥10.0bn
jpcrp040300-q1r_E27054-000Health Care Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥572m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥758m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥758m
jpcrp040300-q1r_E27054-000Others Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥95m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-03-31¥10.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-03-31¥10.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-03-31¥249m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 455
ItemContextValueUnit
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-0JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-0JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration0JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration2000000JPY
Other comprehensive incomePrior1YTDDuration41000000JPY
Other comprehensive incomeCurrentYTDDuration-82000000JPY
Comprehensive incomePrior1YTDDuration-127000000JPY
Comprehensive incomeCurrentYTDDuration109000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration-126000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration109000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-0JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Direct salesPrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember8244000000JPY
Direct salesPrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember-JPY
Direct salesPrior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember-JPY
Direct salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember8244000000JPY
Direct salesPrior1YTDDuration_ReconcilingItemsMember-JPY
Direct salesPrior1YTDDuration8244000000JPY
DistributionPrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember890000000JPY
DistributionPrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember-JPY
DistributionPrior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember-JPY
DistributionPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember890000000JPY
DistributionPrior1YTDDuration_ReconcilingItemsMember-JPY
DistributionPrior1YTDDuration890000000JPY
Original equipment manufacturing material overseasPrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember238000000JPY
Original equipment manufacturing material overseasPrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember-JPY
Original equipment manufacturing material overseasPrior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember-JPY
Original equipment manufacturing material overseasPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember238000000JPY
Original equipment manufacturing material overseasPrior1YTDDuration_ReconcilingItemsMember-JPY
Original equipment manufacturing material overseasPrior1YTDDuration238000000JPY
OthersPrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember652000000JPY
OthersPrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember52000000JPY
OthersPrior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember758000000JPY
OthersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1463000000JPY
OthersPrior1YTDDuration_ReconcilingItemsMember-JPY
OthersPrior1YTDDuration1463000000JPY
Revenue from contracts with customersPrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember10026000000JPY
Revenue from contracts with customersPrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember52000000JPY
Revenue from contracts with customersPrior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember758000000JPY
Revenue from contracts with customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember10837000000JPY
Revenue from contracts with customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenue from contracts with customersPrior1YTDDuration10837000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember10026000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember52000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember758000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember10837000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration10837000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass